APELLIS PHARMACEUTICALS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL KAHN SWICK FOTI LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF 100000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Apellis Pharmaceuticals Inc APLS

NEW ORLEANS, Aug. 08, 2023 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 2, 2023 to file lead plaintiff applications in a securities class action lawsuit against Apellis Pharmaceuticals, Inc.…Read More